CSTL - Company ID 0001447362
CASTLE BIOSCIENCES INC trades as CSTL. In its fiscal 2025 annual report the company posted revenue of $344.23M, up 3.7% from the prior year and net income of -$24.16M. This page tracks CASTLE BIOSCIENCES INC through 828 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 7 fiscal years CASTLE BIOSCIENCES INC's revenue grew from $22.79M to $344.23M, a compound annual growth rate of 47.4%. Net profit margin expanded from -27.9% to -7.0% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-26 |
The largest companies sharing CASTLE BIOSCIENCES INC's SEC industry classification (services-medical laboratories).
CASTLE BIOSCIENCES INC reported revenue of $344.23M for fiscal year 2025, an increase of 3.7% year over year.
In its latest fiscal year CASTLE BIOSCIENCES INC reported a net loss of $24.16M.